More on NMRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+18.2% Growth)
- Ratings (6.4 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neumora Therapeutics (NQ:NMRA)
Delayed: 1.61 +0.01 (0.63%)
Prev. Close $1.60  
Open$1.60 
52 Wk High$ 
52 Wk Low$ 
Day High$1.72 
Day Low$1.59 
P/E N/A  
EPS$ 
Volume1,049,603 


Jul 13, 2026 07:26 AM Neumora Therapeutics (NMRA) PT Lowered to $5 at RBC Capital
Jun 22, 2026 06:45 AM Neumora Therapeutics (NMRA) PT Lowered to $4 at Mizuho
Jun 16, 2026 07:12 AM Neumora Therapeutics (NMRA) PT Lowered to $5 at Needham
Jun 16, 2026 06:46 AM Neumora Therapeutics (NMRA) PT Lowered to $7 at H.C. Wainwright
Jun 15, 2026 08:15 AM Form 8-K Neumora Therapeutics, For: Jun 10
Jun 15, 2026 08:01 AM Neumora Therapeutics (NMRA) Halted, News Pending
Jun 15, 2026 08:00 AM Neumora discontinues navacaprant after phase 3 trials fail primary endpoints
Jun 15, 2026 08:00 AM Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
May 29, 2026 04:34 PM Form 4 Neumora Therapeutics, For: May 27 Filed by: Burow Kristina
May 29, 2026 04:32 PM Form 4 Neumora Therapeutics, For: May 27 Filed by: Fust Matthew K
View All Articles

Entities mentioned with NMRA

View All Entities